IFG Advisory LLC grew its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 281.9% during the third quarter, Holdings Channel reports. The fund owned 12,898 shares of the exchange traded fund’s stock after purchasing an additional 9,521 shares during the period. IFG Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $2,034,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Shah Wealth Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $13,478,000. Wellington Management Group LLP purchased a new stake in SPDR S&P Biotech ETF in the second quarter worth $19,270,000. Ayalon Insurance Comp Ltd. grew its stake in SPDR S&P Biotech ETF by 71.9% in the third quarter. Ayalon Insurance Comp Ltd. now owns 95,600 shares of the exchange traded fund’s stock worth $15,074,000 after purchasing an additional 40,000 shares during the period. Maven Securities LTD purchased a new stake in SPDR S&P Biotech ETF in the second quarter worth $3,028,000. Finally, TD Waterhouse Canada Inc. grew its stake in SPDR S&P Biotech ETF by 535.1% in the second quarter. TD Waterhouse Canada Inc. now owns 5,265 shares of the exchange traded fund’s stock worth $824,000 after purchasing an additional 4,436 shares during the period.
SPDR S&P Biotech ETF Trading Down 3.1%
XBI opened at $145.88 on Tuesday. The stock has a fifty day simple moving average of $153.91 and a two-hundred day simple moving average of $143.02. The company has a market cap of $9.89 billion, a price-to-earnings ratio of 20.64 and a beta of 0.87. SPDR S&P Biotech ETF has a 12-month low of $113.06 and a 12-month high of $169.89.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
